Hope comes to Oxford, England. Drug maker Johnson & Johnson announced plans to test an Ebola vaccine in people with trials at the university, after the doses worked in monkeys. The script calls for two injections, the second developed by a Danish firm. J&J has eyes on a large-scale trial by April, aiming for 2 million doses ready this year. Two other firms are testing their own vaccinations. With some 8,000 stricken in West Africa, protection can’t come soon enough.